Human lifespan evidence: no lifespan RCT — observational association only
Classification
Intervention class: Dietary macronutrient-ratio intervention (total dietary protein, independent of any single amino acid)
Aliases: Dietary protein restriction, Low-protein / high-carbohydrate diet (nutritional-geometry term)
Relationship to mTOR: Dietary amino acids are a major upstream input to mTORC1 via Rag GTPases/Ragulator (see /rag-gtpases) and leucine-Sestrin2 signaling (see downstream outputs on /s6k1, /4e-bp1). Reduced total protein intake is proposed to lower amino-acid-driven mTORC1 input, distinct from restricting any single amino acid -- see /bcaa-restriction and /isoleucine-restriction for the separately-stored amino-acid-specific entities.
Mechanism summary: Reduction of total dietary protein (as opposed to a single amino acid or amino-acid class). Studied in animals via the Solon-Biet nutritional-geometry framework and in humans via prospective observational cohorts; no human RCT of a specific protein-restriction dose against a lifespan or mortality endpoint exists in this dataset.
Regulatory status
Dietary intervention; not a drug. No regulatory approval framework applies.
Evidence per species / population (5-qualifier claim format)
Mouse (Solon-Biet nutritional geometric framework, 25 diets) Tier 6 · Single-lab animal lifespan verification: verified_2026-07-11
1. Species / populationMice, Solon-Biet et al. nutritional-geometry study, 25 distinct diets varying protein:carbohydrate ratio
2. Exposure, route, scheduleDiets spanning a geometric range of protein and carbohydrate ratios (specific ppm/percent values for each of the 25 diets are not enumerated in the sourcing brief)
3. Comparator & durationCross-diet comparison within the same framework; lifespan follow-up
4. Endpoint & numeric resultLongest lifespan observed on low-protein, high-carbohydrate diets, associated with lower circulating IGF-1
5. What this study did NOT establishDid not test humans; did not identify a single optimal human protein target; the association with lower IGF-1 is not established as the causal mechanism for the lifespan difference (see /igf1-signaling for why IGF-1 is not a one-directional lifespan score).
Human (Levine et al., prospective observational cohort, n=6381) Tier 4 · Prospective human observational verification: verified_2026-07-11
1. Species / populationAdults aged 50-65, prospective observational cohort, n=6381 (Levine et al.)
2. Exposure, route, scheduleSelf-reported high dietary protein intake (observational exposure category, not an assigned intervention)
3. Comparator & durationLow dietary protein intake; prospective observational follow-up
4. Endpoint & numeric resultHigh protein intake associated with approximately 75% higher all-cause mortality in the 50-65 age band; association was age-dependent (not the same outside this band) and attenuated for plant-derived protein
5. What this study did NOT establishObservational design -- does not establish causation. No randomized human trial of protein-restriction dose vs. lifespan/mortality exists in this dataset. The effect was age-dependent and attenuated for plant protein, so it cannot be generalized as a single fixed effect across ages or protein sources.
Negative / null / conflicting findings
No human RCT has tested a protein-restriction dose against a lifespan or mortality endpoint; the Levine finding is observational and age-dependent. [study record] verification: verified_2026-07-11
Safety
Safety notes
No human RCT establishing a dose-lifespan or dose-mortality relationship for protein restriction exists in this dataset. General nutritional adequacy of protein intake (avoiding malnutrition/sarcopenia) is a separate, well-established clinical-nutrition question that this longevity-evidence page does not address or override.
Source: (not applicable (no drug label; dietary intervention)) verification: verified_2026-07-11
Editorial policy: This site publishes no protein-restriction dosing calculator and no self-directed protein-restriction protocol.
Data model warning: Total protein restriction, BCAA restriction (/bcaa-restriction), and isoleucine-specific restriction (/isoleucine-restriction) are stored as three SEPARATE intervention entities. Effect sizes reported for one must never be summed, averaged, or substituted for another.
Funding / conflict of interest
Funding sources and conflict-of-interest disclosures for individual studies are not reproduced here pending primary-source verification; see each linked study record.
Related study records
Version 0.2.0-mvp · literature search date 2026-07-11 · editorial owner Nabus Research